Martin Carlsson

MD, PhD, specialised in Endocrinology, Diabetology, Internal medicine and Clinical Chemistry

Martin Carlsson is a physician, Associate Professor and specialist in endocrinology. He is co-founder and Chief Medical Officer at Yazen Health, with a research background in type 2 diabetes, overweight, obesity and the digitalisation of healthcare.

Orange stylized human head with colorful flowers and vines growing out from the top and back.

Martin Carlsson is a physician and specialist in endocrinology/diabetology, internal medicine and clinical chemistry.

He studied medicine at Karolinska Institutet, followed by doctoral research at Lund University on type 2 diabetes and the genetics of overweight and obesity.

Today, he is an Associate Professor at Linnaeus University, with main research interests in hypertension, type 2 diabetes, overweight and obesity, vitamin D, the metabolic syndrome and the digital transformation of healthcare.

Martin has authored more than 40 peer-reviewed scientific papers and contributed to several medical textbooks. He is the founder of the e-health company Accumbo AB (now Blodtrycksdoktorn) and co-founder and Chief Medical Officer of Yazen Health, where he is dedicated to developing the future of care for people living with overweight and obesity.

Articles by

Martin Carlsson

Medicine

Breakthrough weight-loss drug cuts diabetes risk by 94%

Medicine

What to think about when travelling with refrigerated weight loss medication (Wegovy, Ozempic, Mounjaro, Saxenda etc)

Health and lifestyle

Understanding weight gain: The role of genetics, lifestyle, and internal thermostat

Science and publications

New research: over a third of Brits see obesity as a personal choice

A new survey by Yazen Health uncovers widespread misconceptions about obesity, with over one-third of Brits seeing it as a personal choice rather than a chronic disease. These findings highlight the urgent need for greater public education and medically-guided obesity care.

Science and publications

Rethinking Obesity Care Through a Comprehensive Digital Model

The Yazen model integrates medical treatment, behavioural support, education, and social engagement into one continuous digital care pathway. By combining multidisciplinary expertise with high accessibility and ongoing patient interaction, the model aims to support sustainable obesity treatment and long-term health improvement.

Science and publications

Examining the effectiveness of a new digital care model on weight loss for people living with obesity

This real-world evaluation of more than 2,600 patients in Sweden showed that Yazen’s comprehensive digital obesity care model achieved 12.6% weight loss after 6 months, alongside significant improvements in cardiometabolic health markers. The model combines GLP-1 treatment, lifestyle intervention, and continuous multidisciplinary support through a digital platform designed for long-term obesity care.